3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 18, 2013
Grant Date -
Dec 24, 2009
app pub date -
Jun 12, 2009
filing date -
Dec 22, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the use of 3β-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3β-ol-20-one) and/or 3α-hydroxychlormadinone acetate (17α-acetoxychloropregna-4,6-dien-3α-ol-20-one) for producing a medicament for treating skin, preferably human skin by means of topical application, and to a pharmaceutical or cosmetic composition containing 3β-hydroxychlormadinone acetate and/or 3α-hydroxychlormadinone acetate.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully